US COVID-19 Deaths Surpass One Million Amid Concerns Over Rising Cases
The US surpasses one million deaths from COVID-19 as daily case counts rise amidst the lifting of mask mandates and limited access to additional vaccine doses, highlighting ongoing challenges in pandemic control and mitigation efforts.
January 2023
Additional Approach Demonstrates Effectiveness of COVID-19 Vaccines in Reducing Pneumonia
Assessment of pneumonia chest CT scans provides an additional approach to demonstrating the effectiveness of different COVID-19 vaccines in reducing the risk of severe respiratory complications, complementing existing clinical trial data.
January 2023
Diabetic Retinopathy Progression Examined in Adolescents and Young Adults with Type 2 Diabetes
Development and progression of diabetic retinopathy in adolescents and young adults with type 2 diabetes are investigated, providing insights into the ocular complications of early-onset diabetes and informing screening and management guidelines.
January 2023
Social Isolation Linked to Increased Risk of Dementia, Study Suggests
Social isolation is directly associated with a higher risk of later dementia, underscoring the importance of social connections in maintaining cognitive health and highlighting the need for interventions addressing loneliness in older adults.
January 2023
Alcohol's Cardiovascular Risks May Be Underestimated, Study Suggests
A study suggests that the cardiovascular risks associated with alcohol consumption may be more significant than previously thought, highlighting the need for a cautious approach to alcohol consumption and public health interventions to address its adverse effects.
January 2023
CDC Recommends Booster Shots for Children Ages 5 to 11, along with Two Boosters for Adults over 50 and Immunocompromised Individuals
The CDC recommends booster shots for children ages 5 to 11, administered five months after their initial COVID-19 vaccination series, in addition to two booster doses for adults over 50 and immunocompromised individuals, aiming to enhance vaccine-induced immunity and protect vulnerable populations against severe COVID-19 outcomes.
January 2023
Steroid Prescriptions at Discharge Could Alleviate Chronic Inflammation in COVID-19 Survivors
Authors argue for the routine prescription of steroids at discharge for COVID-19 patients to mitigate chronic inflammation and reduce the risk of long-term complications associated with persistent immune dysregulation.
January 2023
